KHELSEA MCCALL: Open Payments
NPI 1245633551 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$234 in 11 payments from 7 companies in 2025. Trend: 2023 $199 · 2024 $221 · 2025 $234
Food & beverage: $234
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 3 | $77 |
| PFIZER INC. | 2 | $43 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Eisai Inc. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| Gilead Sciences, Inc. | 1 | $17 |
| Novocure Inc. | 1 | $15 |
Products named: DATROWAY, Leqembi, Enhertu, IBRANCE, OPDIVO, BOSULIF, KISQALI, Trodelvy.
Industry payments across LA — which companies pay providers there.
